Marlene Thomas: I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders
Marlene Thomas, Head of CGP Portfolio Strategy at Roche, shared on LinkedIn:
“I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders through this year’s program. This open dialogue is instrumental in breaking down barriers and fostering cross-sector collaborations, which can help to accelerate R&D and translate innovation into healthcare systems.
I had the pleasure to co-lead an educational session on ctDNA applications with Umberto Malapelle, Sandi Deans, Anastasios Stathis, and Daniel Shao Weng Tan.
Through liquid biopsy, we are transitioning from detecting individual mutations to gaining a holistic understanding of the disease and with this inform personalised treatment strategies.”
Source: Marlene Thomas/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023